What is the appropriate dosing frequency of Sitcom Forte (calcium‑dobesilate) for a patient after hemorrhoidectomy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Dosing Frequency of Sitcom Forte (Calcium Dobesilate) Post-Hemorrhoidectomy

For post-hemorrhoidectomy patients, calcium dobesilate (Sitcom Forte) should be administered at 500 mg twice daily for symptomatic relief during the recovery period.

Evidence-Based Dosing Recommendation

The standard therapeutic dose of calcium dobesilate for hemorrhoidal disease is 500 mg twice daily 1. This dosing regimen has demonstrated significant efficacy in treating acute hemorrhoidal symptoms with an 86.21% success rate in achieving cessation of bleeding and resolution of inflammation within two weeks 1.

Key Supporting Evidence:

  • Treatment duration: A 2-week course of calcium dobesilate at 500 mg twice daily significantly reduced both symptom scores (from 2 to 0.45) and anoscopic inflammation scores (from 1.69 to 0.55) with P = 0.0001 for both outcomes 1

  • Higher doses: While a 2024 study showed that 1000 mg twice daily provided superior edema reduction in chronic venous insufficiency 2, this was for advanced CVI (CEAP C3-C4), not post-surgical hemorrhoid management

  • Safety profile: The 500 mg twice daily regimen has been well-established as safe and well-tolerated, with no adverse events reported in large observational studies 3

Clinical Application Algorithm

Initiate treatment:

  • Start 500 mg calcium dobesilate twice daily (morning and evening)
  • Begin immediately post-operatively or when oral intake is tolerated
  • Continue for 2-4 weeks during the healing phase

Monitor response at 2 weeks:

  • Assess bleeding cessation
  • Evaluate pain and inflammation reduction
  • Check wound healing progress

Duration considerations:

  • Standard course: 2-4 weeks aligns with typical hemorrhoidectomy recovery (4-8 weeks for complete healing) 4
  • May extend if symptoms persist, but reassess surgical complications if no improvement

Important Clinical Caveats

⚠️ Common pitfall: Do not confuse calcium dobesilate with flavonoids—while both are used for hemorrhoidal disease, flavonoids showed superior efficacy (80.8% vs 67.3% improvement in bleeding) in comparative trials 5. However, calcium dobesilate remains a valid option with proven efficacy.

⚠️ Post-operative context: The provided guidelines 4 emphasize that post-hemorrhoidectomy pain management typically requires narcotic analgesics, with most patients not returning to work for 2-4 weeks. Calcium dobesilate serves as an adjunctive therapy for vascular symptoms and inflammation, not primary pain control.

⚠️ Note on evidence: The FDA drug label provided 6 describes maropitant (an antiemetic for dogs), which is completely irrelevant to this question and should be disregarded.

Practical Implementation

Dosing schedule:

  • 500 mg tablet in the morning with food
  • 500 mg tablet in the evening with food
  • Total daily dose: 1000 mg divided into two administrations

This twice-daily regimen optimizes therapeutic blood levels while maintaining excellent tolerability and addresses the vascular and inflammatory components of post-hemorrhoidectomy recovery 1, 3.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.